Neue Daten zur Device-Therapie

Der interventionelle Vorhofohrverschluss ist eine leitliniengerechte Therapiemöglichkeit für Patienten mit nicht valvulärem Vorhofflimmern, die nicht mit einer Langzeitantikoagulation behandelt werden können.

Implantierbare Loop-Rekorder können bei Verdacht auf kardiale Arrhythmien und bei Hochrisikopatienten ohne klare Ursache für eine Synkope bis zu 3 Jahre den Herzrhythmus beobachten, pathologische Ereignisse erkennen und abspeichern.

Dieser Artikel fasst für beide Verfahren die wichtigsten Fakten zusammen: Indikationen, Durchführung und verfügbare Geräte. Anhand der aktuellen Studiendaten zum interventionellen Vorhofohrverschluss und zum Einsatz von Event-Rekordern werden die derzeitigen Erfahrungen mit den beiden Verfahren dargestellt.

Interventional atrial occlusion is a guideline-compatible treatment option for patients with non-valvular atrial fibrillation that cannot be treated with long-term anticoagulation.

Upon suspicion of cardiac arrhythmias and in high-risk patients with no clear cause for a syncope, implantable loop recorders can observe cardiac rhythm and detect and store pathological events for up to three years.

This article summarizes the most important facts for both procedures: indications, implementation and available devices. On the basis of the current study data regarding interventional atrial occlusion and the use of event recorders, current experiences with the two procedures are presented.

Key words

Left atrial appendage occlusion - non-valvular atrial fibrillation - implantable loop recorder - syncope - arrhythmia

• Literatur

• 1 2016 ESC. Guidelines for the Management of Atrial Fibrillation Developped in Collaboration with EACTS. Eur Heart J 2016; 37: 2893-2962
• 2 Pisters R, Lane DA, Nieuwlaat R et al A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 2010; 138: 1093-1100
• 3 Nakai T, Lesh MD, Gerstenfeld MP et al Percutaneous left atrial appendage occlusion (PLAATO) for preventing cardioembolism first experience in canine model. Circulation 2002; 105: 2217-2222
• 4 Sick PB, Schuler G, Hauptmann KE et al Initial worldwide experience with the WATCHMAN Left Atrial Appendage System for stroke prevention in atrial fibrillation. J Am Coll Cardiol 2007; 49: 1490-1495
• 5 Rogge C, Hilbert S, Dagres N et al [Current state of treatment strategies for atrial fibrillation]. Herz 2016; 41: 253-266
• 6 Thambo JB, Renou P. The future of left atrial appendage occlusions: When extraordinary claims require evidence. Arch Cardiovasc Dis 2015; 108: 613-616
• 7 Price MJ, Gibson DN, Yakubov SJ et al Early safety and efficacy of percutaneous left atrial appendage suture ligation: results from the U.S. transcatheter LAA ligation consortium. J Am Coll Cardiol 2014; 64: 565-572
• 8 Holmes Jr DR, Kar S, Price MJ et al Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol 2014; 64: 1-12
• 9 Boersma LV, Schmidt B, Betts TR. on behalf of the EWOLUTION Investigators. Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry. Eur Heart J 2016; 37: 2465-2474
• 10 Kapoor WN. Evaluation and outcome for patients with syncope. Medicine (Baltimore) 1990; 69: 160-175
• 11 Silverstein MD, Singer DE, Mulley AG et al Patients with syncope admitted to medical intensive care units. JAMA 1982; 248: 1185-1189
• 12 Martin GJ, Adams SL, Martin HG et al Prospective evaluation of syncope. Ann Emerg Med 1984; 13: 499-504
• 13 Kapoor WN, Karpf M, Wieand S et al A prospective evaluation and follow-up of patients with syncope. N Engl J Med 1983; 309: 197-204
• 14 Task Force for the Diagnosis and Management of Syncope. Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J. 2009; 30: 2631-2671
• 15 Vitale E, Ungar A, Maggi R et al Discrepancy between clinical practice and standardized indications for an implantable loop recorder in patients with unexplained syncope. Europace 2010; 12: 1475-1479
• 16 Furukawa T, Maggi R, Bertolone C et al Effectiveness of remote monitoring in the management of syncope and palpitations. Europace 2011; 13: 431-437
• 17 Jauch EC, Saver JL, Adams HP et al Guidelines for the early management of patients with acute ischemic stroke. A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013; 44: 870-947
• 18 Sanna T, Diener HC, Passmann RS et al Crypto-genic stroke and underlying atrial fibrillation. N Engl J Med 2014; 370: 2478-2486
• 19 Healey JS, Connolly SJ, Gold MR et al for the ASSERT Investigators. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med 2012; 366: 120-129
• 20 Huikuri HV, Raatikainen MJ, Moerch-Joergensen R et al Prediction of fatal or near-fatal cardiac arrhythmia events in patients with depressed left ventricular function after an acute myocardial infarction. Eur Heart J 2009; 30: 689-698